# BRIEFING — 2026-10-12T18:50:50Z

## Mission
Adversarially challenge Milestone 2 security (wholesale cost isolation in public APIs, bundles, and flight data) and catalog integrity (115 quoted SKUs accessibility and ligature normalization).

## 🔒 My Identity
- Archetype: EMPIRICAL CHALLENGER
- Roles: critic, specialist
- Working directory: e:\ToolCart\.agents\teamwork\challenger_m2_1
- Original parent: 311a2f36-0bc9-4d2c-ad1b-812679b4333e
- Milestone: Milestone 2
- Instance: 1 of 1

## 🔒 Key Constraints
- Review-only — do NOT modify implementation code
- Must run verification code directly; do not rely on claims or logs without empirical reproduction
- Output challenge report to handoff.md with clear verdict (APPROVE or CHALLENGE_FAILED)
- .agents/teamwork/ must contain only metadata (no code, tests, or data)

## Current Parent
- Conversation ID: 311a2f36-0bc9-4d2c-ad1b-812679b4333e
- Updated: not yet

## Review Scope
- **Files to review**:
  - `e:\ToolCart\.agents\teamwork\ORIGINAL_REQUEST.md`
  - `e:\ToolCart\PROJECT.md`
  - `e:\ToolCart\.agents\teamwork\worker_m2_1\handoff.md`
  - Storefront codebase (`storefront/`), API routes (`/api/store/products`, `/api/store/cart`), Next.js client bundles & flight data
  - Supplier catalog `baseline/10_SAMPLE_SUPPLIER_CATALOG.csv`
- **Interface contracts**: `PROJECT.md`, `AGENTS.md`, `docs/`
- **Review criteria**: Wholesale cost isolation, 115 quoted SKUs slug accessibility, Unicode ligature normalization, verification under stress/adversarial inputs

## Attack Surface
- **Hypotheses tested**: [TBD]
- **Vulnerabilities found**: [TBD]
- **Untested angles**: [TBD]

## Loaded Skills
- None specified by dispatch

## Key Decisions Made
- Initialized briefing and plan to empirically stress-test storefront and data pipeline

## Artifact Index
- `e:\ToolCart\.agents\teamwork\challenger_m2_1\BRIEFING.md` — Persistent working memory
- `e:\ToolCart\.agents\teamwork\challenger_m2_1\progress.md` — Heartbeat and progress tracking
- `e:\ToolCart\.agents\teamwork\challenger_m2_1\handoff.md` — Final challenge report and verdict
